Konferenzposter

Cholestasis reduced hepatic lipid content in HBsAg transgenic mice


AutorenlisteIrungbam, K.; Roderfeld, M.; Churin, Y.; Glimm, H.; Morlock, G.; Yüce, I.

Erschienen inWorkshop Primary Liver Cancer - Emerging Concepts and Novel Treatments : Abstracts, Poster Abstracts : February 13-14, 2020 Johannes Gutenberg-Universität Mainz, Germany

Jahr der Veröffentlichung2020

Seiten22-22

URLhttp://www.falk-foundation-symposia.org/uploads/tx_tocfpshoperw/Workshop_Mainz_2020_Abstracts.pdf



Zitierstile

Harvard-ZitierstilIrungbam, K., Roderfeld, M., Churin, Y., Glimm, H., Morlock, G. and Yüce, I. (2020) Cholestasis reduced hepatic lipid content in HBsAg transgenic mice [Poster], in Workshop Primary Liver Cancer - Emerging Concepts and Novel Treatments : Abstracts, Poster Abstracts : February 13-14, 2020 Johannes Gutenberg-Universität Mainz, Germany. Freiburg: Falk Foundation e.V.. p. 22. http://www.falk-foundation-symposia.org/uploads/tx_tocfpshoperw/Workshop_Mainz_2020_Abstracts.pdf

APA-ZitierstilIrungbam, K., Roderfeld, M., Churin, Y., Glimm, H., Morlock, G., & Yüce, I. (2020). Cholestasis reduced hepatic lipid content in HBsAg transgenic mice. In Workshop Primary Liver Cancer - Emerging Concepts and Novel Treatments : Abstracts, Poster Abstracts : February 13-14, 2020 Johannes Gutenberg-Universität Mainz, Germany. (pp. 22). Falk Foundation e.V.. http://www.falk-foundation-symposia.org/uploads/tx_tocfpshoperw/Workshop_Mainz_2020_Abstracts.pdf


Zuletzt aktualisiert 2025-21-05 um 16:05